Page 131 - 南京医科大学自然版

第44卷第7期 许馨晨，顾莹莹，唐立钧. 影像组学在前列腺癌中的研究进展［J］.
2024年7月 南京医科大学学报（自然科学版），2024，44（7）：1010-1017 ·1015 ·

［13］QI Y F，ZHANG S T，WEI J W，et al. Multiparametric MRI⁃ （2）：243-262
based radiomics for prostate cancer screening with PSA in ［24］KENDRICK J，FRANCIS R，HASSAN G M，et al. Ra⁃
4⁃10 ng/mL to reduce unnecessary biopsies［J］. J Magn diomics for identification and prediction in metastatic
Reson Imaging，2020，51（6）：1890-1899 prostate cancer：a review of studies［J］. Front Oncol，
［14］李梦娟，张彩元，赵文露，等. 基于双参数MRI的影像组 2021，11：771787
学模型在临床显著性前列腺癌中的诊断价值探讨［J］. ［25］SHANKAR P R，KAZA R K，AL⁃HAWARY M M，et al.
磁共振成像，2022，13（11）：76-81 Impact of clinical history on maximum PI⁃RADS version
［15］CHEN T，ZHANG Z Y，TAN S X，et al. MRI based ra⁃ 2 score：a six⁃reader 120⁃case sham history retrospective
diomics compared with the PI⁃RADS V 2.1 in the prediction evaluation［J］. Radiology，2018，288（1）：158-163
of clinically significant prostate cancer：biparametric vs ［26］GONG L X，XU M，FANG M J，et al. Noninvasive predic⁃
multiparametric MRI［J］. Front Oncol，2021，11：792456 tion of high⁃grade prostate cancer via biparametric MRI
［16］BASS E J，PANTOVIC A，CONNOR M，et al. A systematic radiomics［J］. J Magn Reson Imaging，2020，52（4）：
review and meta⁃analysis of the diagnostic accuracy of 1102-1109
biparametric prostate MRI for prostate cancer in men at ［27］WANG X C，ZHANG Y，JI Z G，et al. Old men with pros⁃
risk［J］. Prostate Cancer Prostatic Dis，2021，24（3）：596- tate cancer have higher risk of gleason score upgrading
611 and pathological upstaging after initial diagnosis：a sys⁃
［17］WOO S，SUH C H，KIM S Y，et al. Head⁃to⁃head compari⁃ tematic review and meta⁃analysis［J］. World J Surg On⁃
son between biparametric and multiparametric MRI for col，2021，19（1）：18
the diagnosis of prostate cancer：a systematic review and ［28］ZHANG G M，HAN Y Q，WEI J W，et al. Radiomics
meta⁃analysis［J］. AJR Am J Roentgenol，2018，211（5）： based on MRI as a biomarker to guide therapy by predict⁃
W226-W241 ing upgrading of prostate cancer from biopsy to radical
［18］ALABOUSI M，SALAMEH J P，GUSENBAUER K，et al. prostatectomy［J］. J Magn Reson Imaging，2020，52（4）：
Biparametric vs multiparametric prostate magnetic reso⁃ 1239-1248
nance imaging for the detection of prostate cancer in treat⁃ ［29］OGBONNAYA C N，ZHANG X Y，ALSAEDI B S O，et al.
ment⁃naïve patients：a diagnostic test accuracy systematic Prediction of clinically significant cancer using radiomics
review and meta ⁃ analysis［J］. BJU Int，2019，124（2）： features of pre⁃biopsy of multiparametric MRI in men sus⁃
209-220 pected of prostate cancer［J］. Cancers，2021，13（24）：
［19］BLEKER J，KWEE T C，DIERCKX R A J O，et al. Multi⁃ 6199
parametric MRI and auto⁃fixed volume of interest⁃based ［30］MAKOWSKI M R ，BRESSEM K K ，FRANZ L ，et al.
radiomics signature for clinically significant peripheral De novo radiomics approach using image augmentation
zone prostate cancer［J］. Eur Radiol，2020，30（3）：1313- and features from T1 mapping to predict gleason scores in
1324 prostate cancer［J］. Invest Radiol，2021，56（10）：661-668
［20］CASTILLO T J M，ARIF M，STARMANS M P A，et al. ［31］CASTILLO T J M，STARMANS M P A，ARIF M，et al. A
Classification of clinically significant prostate cancer on multi⁃center，multi⁃vendor study to evaluate the generaliz⁃
multi⁃parametric MRI：a validation study comparing deep ability of a radiomics model for classifying prostate can⁃
learning and radiomics［J］. Cancers，2021，14（1）：12 cer：high grade vs.low grade［J］. Diagnostics，2021，11
［21］MOSES K A，SPRENKLE P C，BAHLER C，et al. NCCN （2）：369
®
guidelines insights：prostate cancer early detection，ver⁃ ［32］ALBERTSEN P C. Radical prostatectomy or watchful wait⁃
sion 1.2023［J］. J Natl Compr Canc Netw，2023，21（3）： ing in prostate cancer⁃29⁃year follow⁃up［J］. Eur Urol，
236-246 2020，78（3）：471
［22］EPSTEIN J I，ZELEFSKY M J，SJOBERG D D，et al. A ［33］JEONG B C，CHALFIN H J，LEE S B，et al. The relation⁃
contemporary prostate cancer grading system：a validated ship between the extent of extraprostatic extension and
alternative to the gleason score［J］. Eur Urol，2016，69 survival following radical prostatectomy［J］. Eur Urol，
（3）：428-435 2015，67（2）：342-346
［23］MOTTET N，VAN DEN BERGH R C N，BRIERS E，et al. ［34］LITWIN M S，TAN H J. The diagnosis and treatment of
EAU⁃EANM⁃ESTRO⁃ESUR⁃SIOG guidelines on prostate prostate cancer：a review［J］. JAMA，2017，317（24）：
cancer⁃2020 update.part 1：screening，diagnosis，and lo⁃ 2532-2542
cal treatment with curative intent［J］. Eur Urol，2021，79 ［35］ROOIJ M D，HAMOEN E H，WITJES J A，et al. Accuracy